Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets sought for canine UTI treatment study
"We need as many vets as possible to share their data and contribute to this vital research" - Fergus Allerton.
Study aims to tackle the threat of antimicrobial resistance.

UK veterinary surgeons are encouraged to take part in a study on antibiotic use in canine urinary tract infections (UTIs).

Led by Fergus Allerton, European Veterinary Specialist in Small Animal Internal Medicine, the study aims to find the optimum length of antibiotic treatment of UTIs in order to combat antimicrobial resistance (AMR), by reducing unnecessary use of antibiotics.

The team requires more than 900 cases from primary care veterinary surgeons across the UK, Fergus Allerton explained:
Treatment recommendations should be based on concrete evidence that improves the care we provide and reduces the risk of unnecessary antibiotic use. 

“Evidence around antibiotic course duration is sorely lacking, but is essential for us address the threat of AMR.

“We are aiming to gather more than 900 cases to provide robust evidence for the study, so we need as many vets as possible to share their data and contribute to this vital research. If you see these cases and would like to help in the fight against AMR please get in touch.”

Titled 'Stop on Sunday' (SOS), the project focuses on treating female dogs with a presumptive diagnosis of UTI, aged between six months and 10 years.

The trial will compare various treatment durations of three, four, five, six and seven-day courses of amoxicillin-clavulanate. The duration assigned with depend on when each dog is presented, those presenting on Monday will receive the full seven-day course, while those presenting on Friday will receive a three-day course. 

On the Monday, the owner of the pet can update the participating veterinary surgeon, who can then reassess the case to ensure that the dog receives the correct level of treatment and support.

A data capture system is used to collected the clinical information, which will email the owners to collect follow-up data in the event of recurrences.

“Input to the study counts towards annual CPD requirements and there will be further opportunities to contribute, such as data analysis and manuscript preparation,” added Mr Allerton. 

The study has ethical approval and an animal test certificate, and is supported by the Small Animal Medicine Society (SAMSoc). 

Full protocol of the study has been published in BMC Veterinary Research, and any veterinary surgeons able to take part can contact fergus.allerton@willows.uk.net for more details.

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.